Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Genes Dev ; 32(13-14): 903-908, 2018 07 01.
Artículo en Inglés | MEDLINE | ID: mdl-29950491

RESUMEN

Loss of function of the DIS3L2 exoribonuclease is associated with Wilms tumor and the Perlman congenital overgrowth syndrome. LIN28, a Wilms tumor oncoprotein, triggers the DIS3L2-mediated degradation of the precursor of let-7, a microRNA that inhibits Wilms tumor development. These observations have led to speculation that DIS3L2-mediated tumor suppression is attributable to let-7 regulation. Here we examine new DIS3L2-deficient cell lines and mouse models, demonstrating that DIS3L2 loss has no effect on mature let-7 levels. Rather, analysis of Dis3l2-null nephron progenitor cells, a potential cell of origin of Wilms tumors, reveals up-regulation of Igf2, a growth-promoting gene strongly associated with Wilms tumorigenesis. These findings nominate a new potential mechanism underlying the pathology associated with DIS3L2 deficiency.


Asunto(s)
Exorribonucleasas/genética , Macrosomía Fetal/genética , Factor II del Crecimiento Similar a la Insulina/genética , Regulación hacia Arriba , Tumor de Wilms/genética , Animales , Línea Celular , Modelos Animales de Enfermedad , Humanos , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos C57BL , MicroARNs/genética , Mutación , Nefronas/citología , Nefronas/fisiopatología , Células Madre
2.
Nature ; 542(7640): 197-202, 2017 02 09.
Artículo en Inglés | MEDLINE | ID: mdl-28114302

RESUMEN

MicroRNAs (miRNAs) perform critical functions in normal physiology and disease by associating with Argonaute proteins and downregulating partially complementary messenger RNAs (mRNAs). Here we use clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated protein 9 (Cas9) genome-wide loss-of-function screening coupled with a fluorescent reporter of miRNA activity in human cells to identify new regulators of the miRNA pathway. By using iterative rounds of screening, we reveal a novel mechanism whereby target engagement by Argonaute 2 (AGO2) triggers its hierarchical, multi-site phosphorylation by CSNK1A1 on a set of highly conserved residues (S824-S834), followed by rapid dephosphorylation by the ANKRD52-PPP6C phosphatase complex. Although genetic and biochemical studies demonstrate that AGO2 phosphorylation on these residues inhibits target mRNA binding, inactivation of this phosphorylation cycle globally impairs miRNA-mediated silencing. Analysis of the transcriptome-wide binding profile of non-phosphorylatable AGO2 reveals a pronounced expansion of the target repertoire bound at steady-state, effectively reducing the active pool of AGO2 on a per-target basis. These findings support a model in which an AGO2 phosphorylation cycle stimulated by target engagement regulates miRNA:target interactions to maintain the global efficiency of miRNA-mediated silencing.


Asunto(s)
Proteínas Argonautas/genética , Proteínas Argonautas/metabolismo , Silenciador del Gen , MicroARNs/genética , Secuencia de Aminoácidos , Proteínas Argonautas/química , Sistemas CRISPR-Cas/genética , Quinasa de la Caseína II/metabolismo , Células HCT116 , Humanos , MicroARNs/metabolismo , Fosfoproteínas Fosfatasas/metabolismo , Fosforilación/genética , ARN Mensajero/genética , ARN Mensajero/metabolismo , Especificidad por Sustrato
3.
Am J Gastroenterol ; 109(3): 325-34, 2014 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-24445574

RESUMEN

OBJECTIVES: The PNPLA3 rs738409 single-nucleotide polymorphism is known to promote nonalcoholic steatohepatitis (NASH), but its association with fibrosis severity and hepatocellular carcinoma (HCC) risk is less well-defined. The objectives of this study were to determine the association between PNPLA3 and liver fibrosis severity, HCC risk, and HCC prognosis among patients with liver disease. METHODS: We performed a systematic literature review using the Medline, PubMed, Scopus, and Embase databases through May 2013 and a manual search of national meeting abstracts from 2010 to 2012. Two investigators independently extracted data on patient populations, study methods, and results using standardized forms. Pooled odds ratios (ORs), according to PNPLA3 genotype, were calculated using the DerSimonian and Laird method for a random effects model. RESULTS: Among 24 studies, with 9,915 patients, PNPLA3 was associated with fibrosis severity (OR 1.32, 95% confidence interval (CI) 1.20-1.45), with a consistent increased risk across liver disease etiologies. Among nine studies, with 2,937 patients, PNPLA3 was associated with increased risk of HCC in patients with cirrhosis (OR 1.40, 95% CI 1.12-1.75). On subgroup analysis, increased risk of HCC was demonstrated in patients with NASH or alcohol-related cirrhosis (OR 1.67, 95% CI 1.27-2.21) but not in those with other etiologies of cirrhosis (OR 1.33, 95% CI 0.96-1.82). Three studies, with 463 patients, do not support an association between PNPLA3 and HCC prognosis but are limited by heterogeneous outcome measures. For all outcomes, most studies were conducted in homogenous Caucasian populations, and studies among racially diverse cohorts are needed. CONCLUSIONS: PNPLA3 is associated with an increased risk of advanced fibrosis among patients with a variety of liver diseases and is an independent risk factor for HCC among patients with nonalcoholic steatohepatitis or alcohol-related cirrhosis.


Asunto(s)
Carcinoma Hepatocelular/genética , Lipasa/genética , Cirrosis Hepática/genética , Neoplasias Hepáticas/genética , Proteínas de la Membrana/genética , Polimorfismo de Nucleótido Simple , Carcinoma Hepatocelular/patología , Progresión de la Enfermedad , Predisposición Genética a la Enfermedad , Humanos , Cirrosis Hepática/diagnóstico , Neoplasias Hepáticas/patología , Medición de Riesgo , Factores de Riesgo
4.
Cell Rep ; 29(10): 3134-3146.e6, 2019 12 03.
Artículo en Inglés | MEDLINE | ID: mdl-31801078

RESUMEN

Sequences within 5' UTRs dictate the site and efficiency of translation initiation. In this study, an unbiased screen designed to interrogate the 5' UTR-mediated regulation of the growth-promoting gene MYC unexpectedly revealed the ribosomal pause relief factor eIF5A as a regulator of translation initiation codon selection. Depletion of eIF5A enhances upstream translation within 5' UTRs across yeast and human transcriptomes, including on the MYC transcript, where this results in increased production of an N-terminally extended protein. Furthermore, ribosome profiling experiments established that the function of eIF5A as a suppressor of ribosomal pausing at sites of suboptimal peptide bond formation is conserved in human cells. We present evidence that proximal ribosomal pausing on a transcript triggers enhanced use of upstream suboptimal or non-canonical initiation codons. Thus, we propose that eIF5A functions not only to maintain efficient translation elongation in eukaryotic cells but also to maintain the fidelity of translation initiation.


Asunto(s)
Codón Iniciador/genética , Factores de Iniciación de Péptidos/genética , Proteínas de Unión al ARN/genética , Ribosomas/metabolismo , Regiones no Traducidas 5'/genética , Línea Celular , Línea Celular Tumoral , Células HCT116 , Células HEK293 , Humanos , Extensión de la Cadena Peptídica de Translación/genética , Biosíntesis de Proteínas/genética , Proteínas Proto-Oncogénicas c-myc/genética , Factor 5A Eucariótico de Iniciación de Traducción
5.
J Clin Invest ; 124(9): 3929-44, 2014 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-25133429

RESUMEN

Spermatogenesis is a complex, multistep process that maintains male fertility and is sustained by rare germline stem cells. Spermatogenic progression begins with spermatogonia, populations of which express distinct markers. The identity of the spermatogonial stem cell population in the undisturbed testis is controversial due to a lack of reliable and specific markers. Here we identified the transcription factor PAX7 as a specific marker of a rare subpopulation of A(single) spermatogonia in mice. PAX7+ cells were present in the testis at birth. Compared with the adult testis, PAX7+ cells constituted a much higher percentage of neonatal germ cells. Lineage tracing in healthy adult mice revealed that PAX7+ spermatogonia self-maintained and produced expanding clones that gave rise to mature spermatozoa. Interestingly, in mice subjected to chemotherapy and radiotherapy, both of which damage the vast majority of germ cells and can result in sterility, PAX7+ spermatogonia selectively survived, and their subsequent expansion contributed to the recovery of spermatogenesis. Finally, PAX7+ spermatogonia were present in the testes of a diverse set of mammals. Our data indicate that the PAX7+ subset of A(single) spermatogonia functions as robust testis stem cells that maintain fertility in normal spermatogenesis in healthy mice and mediate recovery after severe germline injury, such as occurs after cancer therapy.


Asunto(s)
Factor de Transcripción PAX7/fisiología , Células Madre/química , Testículo/citología , Animales , Infertilidad Masculina/etiología , Masculino , Ratones , Factor de Transcripción PAX7/análisis , Espermatogénesis , Espermatogonias/fisiología , Testículo/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA